Answers are grounded in this paper and cite their sources.
Demonstrates a rapid electrochemical method for detecting glycated albumin, highlighting its potential in clinical glycemic monitoring.
This study reports a rapid single-entity electrochemistry (SEE) approach for detecting glycated albumin (GA), a biomarker primarily used for short-term glycaemic monitoring and for clinical situations in which glycated haemoglobin (HbA1c) may be unreliable. Silver nanoparticles (AgNPs) were functionalised with 4-mercaptophenylboronic acid (MPBA) to enable cis-diol affinity interactions with glycated moieties. The MPBA-AgNP conjugates were mixed directly with serum samples, and random nanoparticle collisions at an ultramicroelectrode-generated chronoamperometric transient. A Python-based workflow extracted and classified collision events using peak morphology, and quantification was performed by counting GA-associated events within a 150 s acquisition window. The method provided a linear response from 0.1% to 50% GA (R² = 0.9972 ± 0.0019) and operated in a non-immobilised, mix-and-measure format. These results highlight an ultrafast SEE readout based on single-event counting and interpretable transient features, supporting rapid GA assessment in serum matrices.
No takes yet. Share an insight, caveat, or question.
Zihni Onur Uygun (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: